Functional Precision Medicine: Putting Drugs on Patient Cancer Cells and Seeing What Happens

Area of Science:

• Oncology
• Hematology
• Pharmacology

Background:

• Functional precision medicine assays, which test drug efficacy on patient tumor cells, have historically been underutilized.
• Previous skepticism questioned the clinical utility of these functional assays in cancer treatment.

Purpose of the Study:

• To demonstrate the clinical utility of functional precision medicine assays in hematologic malignancies.
• To validate the effectiveness of drug screening on patient tumor cells for guiding cancer therapy.

Main Methods:

• Exposing patient tumor cells to a range of drugs in vitro.
• Analyzing drug responses to identify effective therapeutic agents for hematologic cancers.

Main Results:

• Two independent research groups provided evidence for the clinical utility of functional precision medicine assays.
• These assays proved effective in identifying active therapies for patients with blood cancers.

Conclusions:

• Functional precision medicine assays are clinically valuable tools for treating hematologic malignancies.
• These assays represent a significant advancement in personalized cancer therapy, particularly for blood cancers.